Skip To Main Content
Ravi A Madan on Muck Rack

Ravi A Madan

As seen in: Color Research & Application, Nature, Wiley, MDPI, The BMJ, Tribune (India), The Lancet, Dove Medical Press, HemOnc Today, Journal of Clinical Oncology and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Ravi A

Contact Ravi A, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Durable responses to triplet immunotherapy targeting TGF-β, PD-L1, and tumor antigen, with an IL-15 receptor superagonist in mismatch repair proficient castration-resistant prostate cancer

|
By Jason Redman, Ravi A Madan, Renee N Donahue
| The BMJ Verified
Immune checkpoint blockade monotherapy has failed to produce reproducible benefit for patients with proficient mismatch repair (pMMR) castration-resistant prostate cancer (CRPC). The Quick Efficacy Seeking Trial is the first in-human evidence suggesting that combination immunotherapy targeting transforming growth factor beta, programmed death-ligand 1, and tumor antigen, with an interleukin-15 receptor superagonist induces durable responses in pMMR CRPC.
Open in Who Shared Issue with article?

Phase II study of olaparib and durvalumab in patients with metastatic castration-resistant prostate cancer

|
By Chennan Li, Ravi A Madan, Min-Jung Lee
| The BMJ Verified
Poly(ADP-ribose) polymerase (PARP) inhibitors benefit selected patients with metastatic castration-resistant prostate cancer (mCRPC), but checkpoint blockade has limited monotherapy activity and PARP–PD-1/PD-L1 combinations have not improved overall survival in biomarker-unselected patients with mCRPC. In a phase 2 trial of olaparib plus durvalumab after androgen receptor pathway inhibitor progression, clinical responses were enriched in BRCA2-altered disease.
Open in Who Shared Issue with article?

Imageine: Sparks of life

|
By Ravi A Madan
| Tribune (India) Verified
Add Tribune As Your Trusted Source Home / Arts / Imageine: Sparks of life Updated At : 05:20 AM Dec 07, 2025 IST Ravi Madan, aka Rockugraphy, is a Gurugram-based retired engineer and a full-time photography enthusiast. He traded the spanner for a viewfinder in pursuit of something far less predictable: fleeting moments of mischief, irony, and quiet magic. Strings of Age. Photo by Ravi Madan.
Open in Who Shared Issue with article?
See all 33 licensed articles (35 Total)